 The primary objective of this study was to assess the safety of FluMist vaccination by comparing the rates of medically attended events MAEs including serious adverse events SAEs, anaphylaxis, urticaria, asthma, wheezing, pre-specified grouped diagnoses, and rare events potentially related to wild-type influenza in FluMist recipients to rates in multiple non-randomized control groups. 